Clinical-stage biopharmaceutical company developing small molecule therapeutics for age-related neurodegenerative diseases.[1]
Get notified the moment COGNITION THERAPEUTICS INC (CGTX) files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.